Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
The United Laboratories International Holdings Limited (HK:3933)
HKEX:3933
The United Laboratories International Holdings (3933) Stock Price & Analysis
0 Followers
3933 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$5.59 - HK$10.78
Previous CloseHK$9.48
Volume7.11M
Average Volume (3M)4.32M
Market Cap
HK$17.23B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)5.8
Beta0.59
Next Earnings
Aug 27, 2024EPS Estimate
HK$0.73Next Dividend Ex-Date
Jul 02, 2024Dividend Yield3.57%
Share Statistics
EPS (TTM)1.64
Shares Outstanding1,817,026,508
10 Day Avg. Volume4,905,000
30 Day Avg. Volume4,315,895
Standard Deviation0.12
R-Squared0.07
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$15.46Price Target Upside63.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
4.80% Mutual Funds
2.75% Other Institutional Investors
92.46% Public Companies and
Individual Investors
3933 FAQ
What was The United Laboratories International Holdings Limited’s price range in the past 12 months?
The United Laboratories International Holdings Limited lowest stock price was HK$5.59 and its highest was HK$10.78 in the past 12 months.
What is The United Laboratories International Holdings Limited’s market cap?
Currently, no data Available
When is The United Laboratories International Holdings Limited’s upcoming earnings report date?
The United Laboratories International Holdings Limited’s upcoming earnings report date is Aug 27, 2024 which is in 96 days.
How were The United Laboratories International Holdings Limited’s earnings last quarter?
The United Laboratories International Holdings Limited released its earnings results on Mar 25, 2024. The company reported HK$0.849 earnings per share for the quarter, beating the consensus estimate of HK$0.781 by HK$0.069.
Is The United Laboratories International Holdings Limited overvalued?
According to Wall Street analysts The United Laboratories International Holdings Limited’s price is currently Undervalued.
Does The United Laboratories International Holdings Limited pay dividends?
The United Laboratories International Holdings Limited pays a Annually dividend of HK$0.3 which represents an annual dividend yield of 3.57%. See more information on The United Laboratories International Holdings Limited dividends here
What is The United Laboratories International Holdings Limited’s EPS estimate?
The United Laboratories International Holdings Limited’s EPS estimate is HK$0.73.
How many shares outstanding does The United Laboratories International Holdings Limited have?
The United Laboratories International Holdings Limited has 1,817,026,500 shares outstanding.
What happened to The United Laboratories International Holdings Limited’s price movement after its last earnings report?
The United Laboratories International Holdings Limited reported an EPS of HK$0.849 in its last earnings report, beating expectations of HK$0.781. Following the earnings report the stock price went up 0.831%.
Which hedge fund is a major shareholder of The United Laboratories International Holdings Limited?
Currently, no hedge funds are holding shares in HK:3933
---
The United Laboratories International Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.91%
12-Months-Change
Fundamentals
Return on Equity
22.95%
Trailing 12-Months
Asset Growth
8.54%
Trailing 12-Months
Company Description
The United Laboratories International Holdings Limited
United Laboratories International Holdings Ltd. operates as an investment company, which engages in the manufacturing and sale of medicines, and the bulk and intermediate products used to produce finished goods. It operates through the following segments: Intermediate Products, Bulk Medicine, and Finished Products. The Intermediate Products segment offers two major products, such as T-Octylammonium Clavulanate and 6-APA. The Bulk Medicine segment includes amoxicillin and insulin. The Finished Products segment includes the sale of antibiotics and non-antibiotics finished products, and capsule casings including Semi-synthetic penicillins antibiotics, Cephalosporins antibiotics, and Insulin products. The company was founded on March 6, 2006 and is headquartered in Hong Kong.
---
3933 Stock 12 Month Forecast
Average Price Target
HK$15.46
▲(63.04% Upside)
Technical Analysis
The United Laboratories International Holdings
―
Perrigo Company
―
Teva Pharmaceutical
―
GlaxoSmithKline
―
AbbVie
―
Best Analysts Covering 3933
1 Year
1 Year Success Rate
5/5 ratings generated profit
1 Year Average Return
+21.00%
reiterated a buy rating 2 months ago
Copying Chris Lui's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +21.00% per trade.
---